Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cole Pinnow currently holds 97,450 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cole Pinnow has been a net neutral trader of COGT stock. They have purchased $0 and sold $0 worth of shares.
Cole Pinnow's most recent insider trade was on Dec 17, 2025, when they sold 50,000 shares at $0.00 per share.
Cole Pinnow serves as Executive at Cogent Biosciences, Inc. (COGT). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Cole Pinnow holds the position of Executive at Cogent Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Cole Pinnow has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cole Pinnow was on Dec 17, 2025, when they sold $3.7M worth of COGT shares. This transaction involved 94,800 shares at $39.45 per share.
Cole Pinnow currently owns 97,450 shares of Cogent Biosciences, Inc. (COGT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cole Pinnow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cole Pinnow has 4 Form 4 filings on record as an insider at Cogent Biosciences, Inc..
Set alerts for Cole Pinnow and 40,000+ other insiders.